Funding for this research was provided by:
National Institute on Aging (K99AG073453)
National Institute of Neurological Disorders and Stroke (K23NS120038)
Article History
Received: 6 October 2023
Accepted: 8 January 2024
First Online: 19 January 2024
Declarations
:
: Data collection was approved by local Institutional Review Boards of all contributing centres and informed consents were obtained from the participants prior to participation.
: Not applicable.
: EB, DGC, RR declare that they have no competing interests. IL’s research is supported by the National Institutes of Health grants: 2R01AG038791-06A, U01NS100610, R25NS098999; U19 AG063911-1 and 1R21NS114764-01A1; the Michael J Fox Foundation, Parkinson Foundation, Lewy Body Association, CurePSP, Roche, Abbvie, Biogen, Centogene. EIP-Pharma, Biohaven Pharmaceuticals, Novartis, and United Biopharma SRL, UCB. She is a member of the Scientific Advisory Board for Amydis, but does not receive funds and from the Rossy PSP Program at the University of Toronto. She receives her salary from the University of California San Diego and as Chief Editor of Frontiers in Neurology.